What does CUSIP 890260862 represent in this 13F holders report?

CUSIP 890260862 is the security identifier for TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW used to aggregate holder disclosures.

How many institutions held TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW in Q3 2022?

25 institutional investors reported TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW for Q3 2022. Use the holders table for investor-level position and value details.

TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP)

CUSIP: 890260862

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / COM NEW
Total 13F shares: 5,583,522
Total 13F value: $2,982,084
Share change: +1,731,180
SEC-reported price per share: $0.53
Number of holders: 25
Value change: +$139,365
Number of buys: 17
Number of sells: 20

Security key

890260862

Report period

Q3 2022

Institutions

Top holders

TNXP full security history Ownership snapshot Full 13F holder table Tonix Pharmaceuticals Holding Corp. SEC filings Tonix Pharmaceuticals Holding Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Murchinson Ltd.

Disclosed value leader

Murchinson Ltd.

Comparable rows

0/15

Latest evidence

30 Jun 2022

13F Highest disclosed value: $5,050,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Murchinson Ltd. has the largest disclosed position value at $5.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Murchinson Ltd.'s linked filing trail.

Disclosed position value Top 5

Murchinson Ltd. $5.05M

MORGAN STANLEY $1.4M

VANGUARD GROUP INC $1.16M

RENAISSANCE TECHNOLOGIES LLC $1.02M

ACADIAN ASSET MANAGEMENT LLC $712K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Murchinson Ltd.	13F Company 13F	— denominator unverified	$5,050,000 500,005 shares	—	30 Jun 2022
MORGAN STANLEY	13F Company 13F	— denominator unverified	$1,402,000 886,332 shares	—	30 Jun 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,157,000 732,180 shares	—	30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$1,016,000 643,124 shares	—	30 Jun 2022
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$712,000 450,696 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$541,000 341,735 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,583,522

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-8

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %